Vicapsys Life Sciences, Inc.

VICP · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$990-$1,182-$985-$237
Dep. & Amort.$0$0$31$31
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$21$106$4
Change in WC$731$629$269-$143
Other Non-Cash$137$115$340-$100
Operating Cash Flow-$122-$418-$238-$444
Investing Activities
PP&E Inv.$0$0-$0$0
Net Acquisitions$0$0$0$100
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$100
Other Inv. Act.$0-$0$0-$100
Investing Cash Flow$0$0$0$100
Financing Activities
Debt Repay.$124$262$0$0
Stock Issued$0$100$35$560
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$50$0$0
Financing Cash Flow$124$413$35$560
Forex Effect$0$0$0$0
Net Chg. in Cash$2-$5-$203$216
Supplemental Information
Beg. Cash$9$14$217$1
End Cash$12$9$14$217
Free Cash Flow-$122-$418-$238-$444
Vicapsys Life Sciences, Inc. (VICP) Financial Statements & Key Stats | AlphaPilot